A Major Win for the Treatment of Nail Psoriasis

被引：0

作者：

Lipner, Shari R. ^{[1
]}

Lebwohl, Mark G. ^{[2
]}

机构：

[1] Weill Cornell Med, Dept Dermatol, New York, NY 10065 USA

[2] Mt Sinai Med Ctr, Dept Dermatol, New York, NY 10029 USA

来源：

JOURNAL OF DRUGS IN DERMATOLOGY | 2017年 / 16卷 / 08期

关键词：

ORAL PHOSPHODIESTERASE-4 INHIBITOR; SEVERE PLAQUE PSORIASIS; PHASE-III; ESTEEM; EFFICACY; APREMILAST; THERAPY; ONYCHOMYCOSIS; MODERATE; DISEASE;

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：731 / 732

页数：2

共 19 条

[1] Nail Psoriasis in Individuals With Psoriasis Vulgaris: A Study of 661 Patients [J].

Armesto, S. ;

Esteve, A. ;

Coto-Segura, P. ;

Drake, M. ;

Galache, C. ;

Martinez-Borra, J. ;

Santos-Juanes, J. .

ACTAS DERMO-SIFILIOGRAFICAS, 2011, 102 (05) :365-372

[2] Treatment of Nail Psoriasis Best Practice Recommendations From the Medical Board of the National Psoriasis Foundation [J].

Crowley, Jeffrey J. ;

Weinberg, Jeffrey M. ;

Wu, Jashin J. ;

Robertson, Andrew D. ;

Van Voorhees, Abby S. .

JAMA DERMATOLOGY, 2015, 151 (01) :87-94

[3] Psoriasis of the nails associated with disability in a large number of patients: Results of a recent interview with 1,728 patients [J].

deJong, EMGJ ;

Seegers, BAMPA ;

Gulinck, MK ;

Boezeman, JBM ;

vandeKerkhof, PCM .

DERMATOLOGY, 1996, 193 (04) :300-303

[4]

Demirsoy EO, 2013, J DRUGS DERMATOL, V12, P1039

[5] Evaluation of the efficacy of methotrexate and cyclosporine therapies on psoriatic nails: a one-blind, randomized study [J].

Gumusel, M. ;

Ozdemir, M. ;

Mevlitoglu, I. ;

Bodur, S. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2011, 25 (09) :1080-1084

[6]

Gupta AK, 1997, BRIT J DERMATOL, V136, P786, DOI 10.1111/j.1365-2133.1997.tb03673.x

[7] Psoriasis of the nail: Anatomy, pathology, clinical presentation, and a review of the literature on therapy [J].

Jiaravuthisan, Michael M. ;

Sasseville, Denis ;

Vender, Ronald B. ;

Murphy, Francis ;

Muhn, Channy Y. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 57 (01) :1-27

[8] Nail Psoriasis, the unknown burden of disease [J].

Klaassen, K. M. G. ;

van de Kerkhof, P. C. M. ;

Pasch, M. C. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 (12) :1690-1695

[9] Nail psoriasis: a questionnaire-based survey [J].

Klaassen, K. M. G. ;

van de Kerkhof, P. C. M. ;

Pasch, M. C. .

BRITISH JOURNAL OF DERMATOLOGY, 2013, 169 (02) :314-319

[10] Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1) [J].

Papp, Kim ;

Reich, Kristian ;

Leonardi, Craig L. ;

Kircik, Leon ;

Chimenti, Sergio ;

Langley, Richard G. B. ;

Hu, ChiaChi ;

Stevens, Randall M. ;

Day, Robert M. ;

Gordon, Kenneth B. ;

Korman, Neil J. ;

Griffiths, Christopher E. M. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (01) :37-49

← 1 2 →